Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): A review
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is a highly pathogenic respiratory virus with mechanisms that may be driven by innate immune responses. Despite the effort of scientific studies related to this virus, Middle East Respiratory Syndrome (MERS) is still a public health concern. ME...
Main Authors: | Sabeena Mustafa, Hanan Balkhy, Musa N. Gabere |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-01-01
|
Series: | Journal of Infection and Public Health |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1876034117302125 |
Similar Items
-
Preventing healthcare-associated transmission of the Middle East Respiratory Syndrome (MERS): Our Achilles heel
by: Hanan H. Balkhy, et al.
Published: (2016-05-01) -
Occurrence of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) across the Gulf Corporation Council countries: Four years update.
by: Mahmoud Aly, et al.
Published: (2017-01-01) -
Critically ill healthcare workers with the Middle East Respiratory Syndrome (MERS)
by: Arabi, Y, et al.
Published: (2017) -
PubMed-cited research articles on the Middle East respiratory syndrome
by: Yaseen Arabi, et al.
Published: (2016-01-01) -
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
by: Ahmad Tavakoli, et al.
Published: (2017-04-01)